Webcast | Virtual
Event Title
FDA Oncology Center of Excellence Presents: Conversations on Cancer: National Hispanic/Latino Family Cancer Awareness Week
September 20, 2024
- Date:
- September 20, 2024
- Time:
- 10:00 a.m. - 12:00 p.m. ET
- Organized By:
-
Organizer
- Sponsored By:
-
Sponsor
Twitter: #ConversationsOnCancer
Background:
Despite advances in cancer prevention and precision cancer care, cancer is the leading cause of death for the Hispanic population in the US. Cancer accounts for the death of about 23,800 Hispanic men and 22,700 Hispanic women. Hispanic individuals have higher rates of infection-related cancers, including approximately two-fold higher incidence of liver and stomach cancer compared to Non-Hispanic White (NHW) individuals. Cervical cancer incidence is 32% higher among Hispanic women in the continental US and Hawaii and 78% higher among women in Puerto Rico compared to Non-Hispanic White women. Hispanic children and adolescents have a significantly higher incidence of several cancers, such as leukemia and lymphoma, and a poorer 5-year overall survival than their NHW counterparts.
The FDA Oncology Center of Excellence Project Community will hold its inaugural National Hispanic/Latino Family Cancer Awareness Week, from September 20 through 26, 2024. The week will feature a Conversation on Cancer public panel discussion on September 20, and a social media campaign throughout the week, using the hashtag #LatinoCancer
The purpose is to increase cancer awareness in the Hispanic/Latino population. National Hispanic/Latino Family Cancer Awareness Week aims to gather community-based groups to increase cancer awareness and build knowledge surrounding cancer clinical trial participation as well as increasing understanding of ways to contribute to national genetic databases for cancer research.
Webcast Information:
A free-of-charge webcast of this public panel discussion will be provided. Registration for the webcast is required at the link above.
FDA plans to post archived webcast of this Conversations on Cancer program at: https://www.fda.gov/about-fda/project-community/conversations-cancer
Contact:
For any inquiries regarding this program, please send an email to: OCE-Engagement@fda.hhs.gov